Treatment breaks

There’s been a lot of discussion about the value and safety of taking a supervised break from your HIV treatments (called a structured treatment interruption). The consensus now is that they may have more risks than benefits, but it's an evolving area of research.

In early 2006 a big international trial called the SMART study, which used CD4 cell counts as a guide to stopping and restarting HIV treatment, was stopped early when it was found that people taking a break from treatment were much more likely to become ill not only because of HIV but due to other serious causes as well. Another treatment interruption study conducted in Africa - an arm of the DART study - was stopped soon after when it was shown that people who took treatment breaks after fixed cycles of treatment were more likely to develop AIDS-defining illnesses.

If you are considering taking a break from your treatment, make sure that you discuss it carefully with your doctor beforehand.

 

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.